Dicerna Pharmaceuticals Inc

Most Recent

  • uploads///Arrowhead
    Company & Industry Overviews

    Arrowhead Pharmaceuticals Stock Has Risen ~252% Year-to-Date

    On November 21, Arrowhead Pharmaceuticals (ARWR) stock closed at $12.95, a ~5.28% rise from its previous day’s close of $12.30.

    By Daniel Collins
  • uploads///red blood cells _
    Company & Industry Overviews

    Why Dicerna Pharmaceuticals Stock Rose 7.7% Yesterday

    On September 13, Dicerna Pharmaceuticals (DRNA) stock rose 7.71% to $16.62 from its previous day’s close of $15.43.

    By Daniel Collins
  • uploads///ALNY
    Earnings Report

    What Alnylam Pharmaceuticals’ Bottom Line Trend Indicates

    Alnylam Pharmaceuticals’ interest income increased from $2.58 million in the second quarter of 2017 to $6.1 million in the second quarter of 2018.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.